Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Current Deferred Revenue (2023 - 2025)

Vsee Health (VSEE) has disclosed Current Deferred Revenue for 3 consecutive years, with $1.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Deferred Revenue rose 68.36% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Sep 2025, up 68.36%, and an annual FY2024 reading of $417815.0, down 53.71% over the prior year.
  • Current Deferred Revenue was $1.2 million for Q3 2025 at Vsee Health, down from $1.2 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $1.2 million in Q2 2025 and bottomed at $87500.0 in Q2 2023.
  • Average Current Deferred Revenue over 3 years is $822857.5, with a median of $896083.5 recorded in 2023.
  • Peak annual rise in Current Deferred Revenue hit 1069.71% in 2024, while the deepest fall reached 53.71% in 2024.
  • Year by year, Current Deferred Revenue stood at $902524.0 in 2023, then plummeted by 53.71% to $417815.0 in 2024, then skyrocketed by 175.26% to $1.2 million in 2025.
  • Business Quant data shows Current Deferred Revenue for VSEE at $1.2 million in Q3 2025, $1.2 million in Q2 2025, and $846674.0 in Q1 2025.